WKN: | A0D9T1 |
ISIN: | US2521311074 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Medizintechnik |
Weshalb die Dexcom-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 17. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2009 | 0,3900 | 1,3800 | 253,85% |
2 | 2013 | 2,4900 | 6,3200 | 153,82% |
3 | 2018 | 11,8500 | 25,4200 | 114,51% |
4 | 2019 | 25,4200 | 48,3300 | 90,13% |
5 | 2010 | 1,3800 | 2,6100 | 89,13% |
6 | 2014 | 6,3200 | 11,4300 | 80,85% |
7 | 2015 | 11,4300 | 18,6400 | 63,08% |
8 | 2021 | 72,7400 | 116,2500 | 59,82% |
9 | 2020 | 48,3300 | 72,7400 | 50,51% |
10 | 2012 | 1,7600 | 2,4900 | 41,48% |
11 | 2023 | 104,4000 | 111,9600 | 7,24% |
12 | 2025 | 76,4500 | 73,3400 | -4,07% |
13 | 2022 | 116,2500 | 104,4000 | -10,19% |
14 | 2017 | 14,2800 | 11,8500 | -17,02% |
15 | 2007 | 1,8800 | 1,5300 | -18,62% |
16 | 2016 | 18,6400 | 14,2800 | -23,39% |
17 | 2024 | 111,9600 | 76,4500 | -31,72% |
18 | 2011 | 2,6100 | 1,7600 | -32,57% |
19 | 2006 | 3,1800 | 1,8800 | -40,88% |
20 | 2008 | 1,5300 | 0,3900 | -74,51% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 1,5300 | 0,3900 | -74,51% |
2 | 2006 | 3,1800 | 1,8800 | -40,88% |
3 | 2011 | 2,6100 | 1,7600 | -32,57% |
4 | 2024 | 111,9600 | 76,4500 | -31,72% |
5 | 2016 | 18,6400 | 14,2800 | -23,39% |
6 | 2007 | 1,8800 | 1,5300 | -18,62% |
7 | 2017 | 14,2800 | 11,8500 | -17,02% |
8 | 2022 | 116,2500 | 104,4000 | -10,19% |
9 | 2025 | 76,4500 | 73,3400 | -4,07% |
10 | 2023 | 104,4000 | 111,9600 | 7,24% |
11 | 2012 | 1,7600 | 2,4900 | 41,48% |
12 | 2020 | 48,3300 | 72,7400 | 50,51% |
13 | 2021 | 72,7400 | 116,2500 | 59,82% |
14 | 2015 | 11,4300 | 18,6400 | 63,08% |
15 | 2014 | 6,3200 | 11,4300 | 80,85% |
16 | 2010 | 1,3800 | 2,6100 | 89,13% |
17 | 2019 | 25,4200 | 48,3300 | 90,13% |
18 | 2018 | 11,8500 | 25,4200 | 114,51% |
19 | 2013 | 2,4900 | 6,3200 | 153,82% |
20 | 2009 | 0,3900 | 1,3800 | 253,85% |